X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.9%
5Y CAGR+13.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+9.9%/yr
vs +17.3%/yr prior
5Y CAGR
+13.1%/yr
Recent deceleration
Acceleration
-7.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $116.24M | +204.6% |
| 2024 | $38.16M | -64.5% |
| 2023 | $107.52M | +22.8% |
| 2022 | $87.57M | +2.9% |
| 2021 | $85.11M | +35.4% |
| 2020 | $62.87M | +31.5% |
| 2019 | $47.80M | +3.5% |
| 2018 | $46.21M | +43.2% |
| 2017 | $32.27M | +47.0% |
| 2016 | $21.96M | - |